Urologic Oncology: Prostate Cancer
- PMID: 37334535
- DOI: 10.1097/JU.0000000000003587
Urologic Oncology: Prostate Cancer
Comment on
-
Rucaparib or Physician's Choice in Metastatic Prostate Cancer.N Engl J Med. 2023 Feb 23;388(8):719-732. doi: 10.1056/NEJMoa2214676. Epub 2023 Feb 16. N Engl J Med. 2023. PMID: 36795891 Free PMC article. Clinical Trial.
-
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.N Engl J Med. 2023 Apr 27;388(17):1547-1558. doi: 10.1056/NEJMoa2214122. Epub 2023 Mar 11. N Engl J Med. 2023. PMID: 36912538 Clinical Trial.
Similar articles
-
Urologic Oncology: Prostate Cancer.J Urol. 2023 Nov;210(5):822-824. doi: 10.1097/JU.0000000000003675. Epub 2023 Aug 25. J Urol. 2023. PMID: 37622534 No abstract available.
-
Urologic Oncology: Prostate Cancer.J Urol. 2023 Oct;210(4):717. doi: 10.1097/JU.0000000000003633. Epub 2023 Jul 28. J Urol. 2023. PMID: 37503946 No abstract available.
-
Urologic Oncology: Prostate Cancer.J Urol. 2023 Aug;210(2):381-382. doi: 10.1097/JU.0000000000003541. Epub 2023 May 18. J Urol. 2023. PMID: 37199093 No abstract available.
-
[Monoclonal antibodies in urology. Basic theories and clinical applications].Ann Urol (Paris). 1985;19(1):7-12. Ann Urol (Paris). 1985. PMID: 3885840 Review. French.
-
Changing the script: (In)Equities in urologic oncology care.Urol Oncol. 2022 Apr;40(4):115-116. doi: 10.1016/j.urolonc.2019.06.011. Epub 2019 Jul 17. Urol Oncol. 2022. PMID: 31324456 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical